Short interest in Franklin Genomic Advancements ETF (BATS:HELX) decreased during the last reporting period, falling from 8.36K to 712.00. This put -% of the company's publicly available shares short.

Short interest for Franklin Genomic Advancements ETF gives investors a sense of the degree to which investors are betting on the decline of Franklin Genomic Advancements ETF's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 7.63K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.